COSMOS Pharmaceutical Corporation (CSMYF)
USD 46.06
(0.0%)
USD 46.06
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 24.45 Billion JPY | 2.76% |
| 2023 | 23.79 Billion JPY | 2.77% |
| 2022 | 23.15 Billion JPY | -14.73% |
| 2021 | 27.15 Billion JPY | 26.69% |
| 2020 | 21.43 Billion JPY | 11.73% |
| 2019 | 19.18 Billion JPY | 8.8% |
| 2018 | 17.63 Billion JPY | -3.2% |
| 2017 | 18.21 Billion JPY | 46.48% |
| 2016 | 12.43 Billion JPY | 6.34% |
| 2015 | 11.69 Billion JPY | 10.32% |
| 2014 | 10.6 Billion JPY | 12.81% |
| 2013 | 9.39 Billion JPY | 21.44% |
| 2012 | 7.73 Billion JPY | 34.86% |
| 2011 | 5.73 Billion JPY | 21.75% |
| 2010 | 4.71 Billion JPY | 65.86% |
| 2009 | 2.84 Billion JPY | 30.74% |
| 2008 | 2.17 Billion JPY | -5.48% |
| 2007 | 2.29 Billion JPY | 18.26% |
| 2006 | 1.94 Billion JPY | 54.41% |
| 2005 | 1.25 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | 24.45 Billion JPY | 2.76% |
| 2024 Q4 | 7.09 Billion JPY | 23.0% |
| 2024 Q3 | 5.77 Billion JPY | 13.61% |
| 2024 Q1 | 6.5 Billion JPY | -13.39% |
| 2024 Q2 | 5.07 Billion JPY | -21.96% |
| 2023 FY | 23.79 Billion JPY | 2.77% |
| 2023 Q2 | 4.81 Billion JPY | -25.66% |
| 2023 Q3 | 4.98 Billion JPY | 3.45% |
| 2023 Q4 | 7.51 Billion JPY | 50.76% |
| 2023 Q1 | 6.48 Billion JPY | -3.27% |
| 2022 Q3 | 5.21 Billion JPY | 4.16% |
| 2022 FY | 23.15 Billion JPY | -14.73% |
| 2022 Q4 | 6.7 Billion JPY | 28.6% |
| 2022 Q2 | 5 Billion JPY | -19.88% |
| 2022 Q1 | 6.24 Billion JPY | 11.98% |
| 2021 Q1 | 7.49 Billion JPY | 4.09% |
| 2021 Q2 | 5.58 Billion JPY | -25.47% |
| 2021 Q4 | 5.57 Billion JPY | -34.48% |
| 2021 Q3 | 8.5 Billion JPY | 52.44% |
| 2021 FY | 27.15 Billion JPY | 26.69% |
| 2020 Q1 | 5.04 Billion JPY | -15.54% |
| 2020 Q4 | 7.19 Billion JPY | 31.6% |
| 2020 FY | 21.43 Billion JPY | 11.73% |
| 2020 Q3 | 5.46 Billion JPY | 46.91% |
| 2020 Q2 | 3.72 Billion JPY | -26.28% |
| 2019 FY | 19.18 Billion JPY | 8.8% |
| 2019 Q3 | 4.2 Billion JPY | 1.99% |
| 2019 Q4 | 5.97 Billion JPY | 42.27% |
| 2019 Q1 | 4.88 Billion JPY | -15.18% |
| 2019 Q2 | 4.12 Billion JPY | -15.66% |
| 2018 Q2 | 3.14 Billion JPY | -32.23% |
| 2018 FY | 17.63 Billion JPY | -3.2% |
| 2018 Q4 | 5.75 Billion JPY | 40.7% |
| 2018 Q3 | 4.09 Billion JPY | 30.23% |
| 2018 Q1 | 4.63 Billion JPY | -17.71% |
| 2017 Q1 | 4.61 Billion JPY | 42.72% |
| 2017 Q4 | 5.63 Billion JPY | 44.66% |
| 2017 FY | 18.21 Billion JPY | 46.48% |
| 2017 Q2 | 4.06 Billion JPY | -11.81% |
| 2017 Q3 | 3.89 Billion JPY | -4.25% |
| 2016 Q2 | 2.76 Billion JPY | -17.89% |
| 2016 FY | 12.43 Billion JPY | 6.34% |
| 2016 Q3 | 3.06 Billion JPY | 10.77% |
| 2016 Q1 | 3.37 Billion JPY | -4.69% |
| 2016 Q4 | 3.23 Billion JPY | 5.48% |
| 2015 FY | 11.69 Billion JPY | 10.32% |
| 2015 Q1 | 2.71 Billion JPY | 8.0% |
| 2015 Q2 | 2.64 Billion JPY | -2.62% |
| 2015 Q3 | 2.8 Billion JPY | 5.98% |
| 2015 Q4 | 3.53 Billion JPY | 26.24% |
| 2014 Q1 | 3.12 Billion JPY | 36.95% |
| 2014 FY | 10.6 Billion JPY | 12.81% |
| 2014 Q4 | 2.51 Billion JPY | 4.01% |
| 2014 Q3 | 2.41 Billion JPY | -5.25% |
| 2014 Q2 | 2.55 Billion JPY | -18.3% |
| 2013 Q4 | 2.27 Billion JPY | 12.54% |
| 2013 FY | 9.39 Billion JPY | 21.44% |
| 2013 Q1 | 2.96 Billion JPY | 44.92% |
| 2013 Q2 | 2.12 Billion JPY | -28.44% |
| 2013 Q3 | 2.02 Billion JPY | -4.66% |
| 2012 Q1 | 2.24 Billion JPY | 30.54% |
| 2012 FY | 7.73 Billion JPY | 34.86% |
| 2012 Q3 | 1.69 Billion JPY | -2.8% |
| 2012 Q2 | 1.74 Billion JPY | -22.15% |
| 2012 Q4 | 2.04 Billion JPY | 20.61% |
| 2011 FY | 5.73 Billion JPY | 21.75% |
| 2011 Q4 | 1.71 Billion JPY | 30.23% |
| 2011 Q1 | 1.46 Billion JPY | 1.6% |
| 2011 Q2 | 1.23 Billion JPY | -15.78% |
| 2011 Q3 | 1.32 Billion JPY | 7.06% |
| 2010 Q2 | 1.31 Billion JPY | -3.1% |
| 2010 Q1 | 1.35 Billion JPY | 15.92% |
| 2010 Q4 | 1.44 Billion JPY | 59.23% |
| 2010 FY | 4.71 Billion JPY | 65.86% |
| 2010 Q3 | 905 Million JPY | -31.02% |
| 2009 Q2 | 692 Million JPY | 0.0% |
| 2009 Q4 | 1.16 Billion JPY | 73.81% |
| 2009 FY | 2.84 Billion JPY | 30.74% |
| 2009 Q3 | 672 Million JPY | -2.89% |
| 2008 FY | 2.17 Billion JPY | -5.48% |
| 2007 FY | 2.29 Billion JPY | 18.26% |
| 2006 FY | 1.94 Billion JPY | 54.41% |
| 2005 FY | 1.25 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -3703.18 USD | 660351473.684% |
| Allstar Health Brands, Inc. | -499.34 Thousand USD | 4897334.967% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 69.18 Million USD | -35245.038% |
| Café Serendipity Holdings, Inc. | -750.15 Thousand USD | 3259950.938% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -49.02 Thousand USD | 49883825.674% |
| HealthWarehouse.com, Inc. | -1.77 Million USD | 1378893.175% |
| LIGAND PHARMACEUTICAL INC | 52.15 Million USD | -46788.062% |
| MedGen, Inc. | -15.54 USD | 157361647461.647% |
| Omni Health, Inc. | 1.26 Million USD | -1932046.528% |
| Oxford Investments Holdings Inc. | -299.1 Thousand USD | 8175878.912% |
| Pineapple, Inc. | -1.47 Million USD | 1655040.73% |
| ScripsAmerica, Inc. | -4.73 Million USD | 516983.581% |